Acquired resistance to LY2874455 in FGFR2-amplified gastric cancer through an emergence of novel FGFR2-ACSL5 fusion

BACKGROUND: Fibroblast growth factor 2 (FGFR2) amplification, occurring in ~2–9% of gastric cancers (GC), is associated with poor overall survival. RESULTS: RNA sequencing identified a novel FGFR2-ACSL5 fusion in the resistant tumor that was absent from the matched pre-treatment tumor. The FGFR2-amp...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Oncotarget
Glavni autori: Kim, Sun Young, Ahn, Taejin, Bang, Heejin, Ham, Jun Soo, Kim, Jusun, Kim, Seung Tae, Jang, Jiryeon, Shim, Moonhee, Kang, So Young, Park, Se Hoon, Min, Byung Hoon, Lee, Hyuk, Kang, Won Ki, Kim, Kyoung-Mee, Park, Woongyang, Lee, Jeeyun
Format: Artigo
Jezik:Inglês
Izdano: Impact Journals LLC 2017
Teme:
Research Paper
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5362463/
https://ncbi.nlm.nih.gov/pubmed/28122360
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.14788
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items